← FDA DRUG APPROVALS

FDA ANDA · ANDA073548

DESONIDE

Sponsor: SUN PHARMA CANADA

APPLICATION
ANDA073548
TYPE
ANDA
ORIGINAL APPROVAL
1992-06-30
LATEST ACTION
2016-01-15
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription

Products

DESONIDEPrescription
DESONIDE 0.05% · CREAM · TOPICAL

Approval history

2016-01-15Labeling · Supplement 27 · standardAP
1999-08-18Manufacturing (CMC) · Supplement 7AP
1999-06-18Manufacturing (CMC) · Supplement 8AP
1998-01-20Manufacturing (CMC) · Supplement 6AP
1997-10-17Manufacturing (CMC) · Supplement 4AP
1997-10-17Manufacturing (CMC) · Supplement 5AP
1996-09-17Manufacturing (CMC) · Supplement 3AP
1996-08-01Manufacturing (CMC) · Supplement 2AP
1996-08-01Manufacturing (CMC) · Supplement 1AP
1992-06-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →